Answers are grounded in this paper and cite their sources.
Metabolic Syndrome (MetS) is a cluster of risk factors, including central obesity, dyslipidemia, hypertension, and insulin resistance, which increases the risk of Cardiovascular Disease (CVD), stroke, and type 2 diabetes. The Atherogenic Index of Plasma (AIP), calculated as the logarithmic ratio of Triglycerides (TGs) to High-density Lipoprotein (HDL) Cholesterol, is a novel and sensitive biomarker for CVD risk stratification. A 35-year-old female with Body Mass Index (BMI) of 33.3 kg/m 2 (Class I obesity) presented with waist circumference of 100 cm and TG and HDL levels 240 mg/dL and 16 mg/dL, respectively, Blood Pressure (BP) of 140/90 mmHg and AIP of 0.816 (high cardiovascular risk). Ayurveda diagnostic assessment confirmed Medovaha srotodushti (~derangement of channels carrying fat tissue). Thus, the line of management focused on Kapha medohara (~ Kapha and fat tissue reducing) therapies such as Udvartana (~therapeutic powder massage), Snehapana (~internal oleation), Virechana (~therapeutic purgation), followed by Shamana (~pacification) therapy with Vyoshadi saktu along with dietary and lifestyle modifications. Posttreatment, reduction in AIP by 80% to 0.157 (intermediate risk), waist circumference: 93 cm, TG: 125 mg/dL, HDL: 38 mg/dL, BP: 130/85 mmHg, BMI: 28.2 kg/m 2 (overweight), along with improvement in serum uric acid and C-reactive protein was reported. This case report demonstrates the effectiveness of Shodhana and Shamana therapies in improving MetS components and reducing CVD risk, as evidenced by the significant decline in AIP.
No takes yet. Share an insight, caveat, or question.
Kuraakula et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: